Evaluation of 3APS in Patients With Mild to Moderate Alzheimer's Disease

Phase 3 Unknown 950 enrolled Bellus Health Inc. - a GSK company

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this Phase III study is to evaluate the efficacy and safety of 3APS compared to placebo (inactive substance pill) in patients with mild to moderate Alzheimer's disease.

Timeline

Start: 2004-06
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	3APS	Unknown	—	—

Evaluation of 3APS in Patients With Mild to Moderate Alzheimer's Disease

Summary

Timeline

Drugs

Indications